๐ฐ Soft Tissue News
Page 3 - Soft Tissue News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Soft Tissue. Real-time updates on events, politics, business and more.
April 30, 2024
Axogen announced the first surgical implantation of its Avive+ Soft Tissue Matrix, a resorbable, multi-layer, placenta-based allograft.
April 23, 2024
Shawn Mendes Spotted with Dr. Jocelyne Miranda for First Time in Months, Seen on Friendly Walk Shawn Mendes and his longtime friend Dr. Jocelyne Miranda are hanging out together again! The 25-year-old โStitchesโ hitmaker and the 52-year-old doctor were…
March 28, 2024
Here's a special advertising feature with a twist of April Fool's Day fun and the chance to win a free night's accommodation for two, valued at $1850 at the award-winning Jamala Wildlife Lodge at the National Zoo and Aquarium.
March 12, 2024
Soft tissue sarcoma is a rare cancer of connective tissue that can affect soft tissues such as fat, muscle, nerves and blood vessels of any body part.
February 27, 2024
The company's devices, BioZorb Marker and BioZorb LP Marker, are implanted in soft tissue, including breast tissue, where the site needs to be marked for future procedures, such as radiation for breast cancer treatment. The Food and Drug Administration said it has received reports on complications related to the use of the devices in breast tissue including infection, fluid buildup, device moving out of its position and breaking through the skin. It has also received reports of pain, disc...
February 16, 2024
The FDA has granted an orphan drug designation to tigilanol tiglate for the treatment of patients with soft tissue sarcoma.
February 16, 2024
Tigilanol tiglate is a novel, small molecule drug for the intratumoral treatment of solid tumors, inducing tumor cell death and stimulating immune response.
February 2, 2024
A microscope scientist working for California State University has been fired following the discovery that a Triceratops horn still contained soft tissue
January 30, 2024
Media Release Excellent clinical data reported from TACTI-002 Phase II trial, including median Overall Survival of 35.5 months in first line non-small cell lung cancer patients expressing PD-L1...
January 23, 2024
Dublin, Jan. 22, 2024 (GLOBE NEWSWIRE) -- The